logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Transgenomic, Inc.


USPTO Granted Patents = 69

% Expired Patents = 24.6


Trademarks = 2

Forward Citations = 523

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Douglas T Gjerde (49 out of 103 patents)

silverMedal Paul D Taylor (36 out of 37 patents)

bronzeMedal Robert M Haefele (31 out of 31 patents)

4.  David W Togami (11 out of 11 patents)

5.  Christopher P Hanna (8 out of 16 patents)

6.  Robert C Fry (4 out of 10 patents)

7.  David P Hornby (4 out of 4 patents)

8.  John E Sutton (4 out of 4 patents)

9.  Gary Floyd Gerard (4 out of 21 patents)

10.  Xue-Feng Pei (3 out of 3 patents)

11.  Baoqing Li (3 out of 3 patents)

12.  Maria-Luisa Maccecchini (3 out of 9 patents)

13.  Karl H Hecker (3 out of 3 patents)

14.  Kimberly A Lamb (3 out of 3 patents)

15.  Arthur P D'Silva (3 out of 10 patents)


Core Competencies:
Polynucleotide
Chromatography
Mutation Detection
Liquid Chromatography
Endonuclease
DNA Separation
RNA Analysis
Nucleic Acid
Capillary Columns
MIPC
Separation Techniques
Automated Systems

69 patents:

1. 9133490 - Step-up method for COLD-PCR enrichment (2015-09-15),
2. 8658358 - Mutations associated with long QT syndrome (2014-02-25),
3. 7749708 - Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule (2010-07-06),
4. 7579155 - Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule (2009-08-25),
5. 7560261 - Nucleic acid sequences encoding CEL II endonuclease (2009-07-14),
6. 7225079 - System and method for automated matched ion polynucleotide chromatography (2007-05-29),
7. 7169298 - Method and apparatus for separating polynucleotides using monolithic capillary columns (2007-01-30),
8. 7138518 - Liquid chromatographic separation of polynucleotides (2006-11-21),
9. 7135289 - Methods and compositions for mutation analysis of polynucleotides by liquid chromatography (2006-11-14),
10. 7129075 - Isolated CEL II endonuclease (2006-10-31),
11. 6894048 - Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors (2005-05-17),
12. 6887867 - 5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors (2005-05-03),
13. 6838242 - Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography (2005-01-04),
14. 6737022 - Fragment collector apparatus (2004-05-18),
15. 6703390 - Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors (2004-03-09),
Transgenomic, Inc. is a global biotechnology company specializing in genetic variation analysis. They provide advanced molecular diagnostic tests, genetic analysis tools, and clinical and research services to assist researchers, clinicians, and healthcare professionals in disease identification and treatment. With a focus on personalized medicine, Transgenomic aims to improve patient outcomes through innovative genomic technologies and solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Transgenomic, Inc.
69 Patents

#147 in San Jose, CA

#1,237 in California

#5,298 in US

#10,745 in the World

San Jose, CA (US)
San Jose, CA, United States of America

Transgenomic, Inc.

Forward Citations = 523

46 inventors:

goldMedal Douglas T Gjerde (49 out of 103 patents)

silverMedal Paul D Taylor (36 out of 37 patents)

bronzeMedal Robert M Haefele (31 out of 31 patents)

4.  David W Togami (11 out of 11 patents)

5.  Christopher P Hanna (8 out of 16 patents)

Please report any incorrect information to [email protected]
Loading…